StockTipsArenaBeta

BUY Ajanta Pharma Limited — Aastha Jain, Hem Securities

BUYAjanta Pharma Limited
Ajanta Pharma share price target & all analyst calls

byAastha Jain, Hem SecuritiesHorizon: BTST30 Sept 2026, 11:22 am ISTvia Zee Business (Live)

Entry₹3,621.6Inferred
Target₹3,800
Total upside +4.93%
Stop loss₹3,566-1.54% risk
CMP₹3,620.86h ago
Active-0.02%+4.95%upside left 16h left
Follow Aastha Jain for new calls(20% target hit, 51 closed calls)Get alertsWatch AJANTPHARM for new buy/sell callsGet alertsSee 3 other BTST picks this session

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

AI Assessment

Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.

As of 30 Sept, 11:05 pm IST
4 supporting0 opposing
Supports the BUY call (4)

Volume 4.1× its 30-day average

Technicals · volume·30 Sept · today

Ajanta Pharma promoter releases pledge on 98,185 shares for loan repayment

NewsGoogle News·28 Sept · 2d ago

(opens in new tab)

1 advisor has an active swing BUY call on this stock, issued in the last 14 days

Advisor consensus · adjacent horizon·24 Sept · 6d ago

Ajanta Pharma's Geographical Diversification Delivers

NewsGoogle News·23 Sept · 1w ago

(opens in new tab)
Neutral / worth noting (0)

Nothing found in this tip’s window yet.

Weighs against the BUY call (0)

Nothing found in this tip’s window yet.

Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.

StockTipsArena© 2026 · NSE equities only · Not investment advicePublic beta · data is auto-aggregated from public sources and may contain errors — verify before acting.